Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GEMS Wraps Up OR Holiday Wish List With $2 Bil. Instrumentarium Buy

This article was originally published in The Gray Sheet

Executive Summary

GE Medical Systems plans to grow Instrumentarium's business in excess of 20% over the next several years following its $2.06 bil. acquisition of the Finnish firm

You may also be interested in...



GE Response To EU Instrumentarium Merger Objections: Jettison Spacelabs?

GE Medical Systems is hoping that limited divestitures will be sufficient to earn EU regulatory clearance for its pending $2 bil. purchase of Instrumentarium

GE Response To EU Instrumentarium Merger Objections: Jettison Spacelabs?

GE Medical Systems is hoping that limited divestitures will be sufficient to earn EU regulatory clearance for its pending $2 bil. purchase of Instrumentarium

GE Revises Instrumentarium Buy-Out Date In Face Of Anti-Trust Scrutiny

GE Medical Systems' decision to extend the timing of its tender offer for Instrumentarium suggests the company may be forced to divest some critical care or imaging assets in order for the merger to earn European and U.S. anti-trust approval

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017661

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel